Association of alcohol use with years lived without major chronic diseases: A multicohort study from the IPD-Work consortium and UK Biobank.

Alcohol consumption Binge drinking Chronic diseases Disease-free life-years

Journal

The Lancet regional health. Europe
ISSN: 2666-7762
Titre abrégé: Lancet Reg Health Eur
Pays: England
ID NLM: 101777707

Informations de publication

Date de publication:
Aug 2022
Historique:
entrez: 6 6 2022
pubmed: 7 6 2022
medline: 7 6 2022
Statut: epublish

Résumé

Heavy alcohol consumption increases the risk of several chronic diseases. In this multicohort study, we estimated the number of life-years without major chronic diseases according to different characteristics of alcohol use. In primary analysis, we pooled individual-level data from up to 129,942 adults across 12 cohort studies with baseline data collection on alcohol consumption, drinking patterns, and history between 1986 and 2005 (the IPD-Work Consortium). Self-reported alcohol consumption was categorised according to UK guidelines - non-drinking (never or former drinkers); moderate consumption (1-14 units); heavy consumption (>14 units per week). We further subdivided moderate and heavy drinkers by binge drinking pattern (alcohol-induced loss of consciousness). In addition, we assessed problem drinking using linked data on hospitalisations due to alcohol abuse or poisoning. Follow-up for chronic diseases for all participants included incident type 2 diabetes, coronary heart disease, stroke, cancer, and respiratory disease (asthma and chronic obstructive pulmonary disease) as ascertained via linkage to national morbidity and mortality registries, repeated medical examinations, and/or self-report. We estimated years lived without any of these diseases between 40 and 75 years of age according to sex and characteristics of alcohol use. We repeated the main analyses using data from 427,621 participants in the UK Biobank cohort study. During 1·73 million person-years at risk, 22,676 participants in IPD-Work cohorts developed at least one chronic condition. From age 40 to 75 years, never-drinkers [men: 29·3 (95%CI 27·9-30·8) years, women 29·8 (29·2-30·4) years)] and moderate drinkers with no binge drinking habit [men 28·7 (28·4-29·0) years, women 29·6 (29·4-29·7) years] had the longest disease-free life span. A much shorter disease-free life span was apparent in participants who experienced alcohol poisoning [men 23·4 (20·9-26·0) years, women 24·0 (21·4-26·5) years] and those with self-reported heavy overall consumption and binge drinking [men: 26·0 (25·3-26·8), women 27·5 (26·4-28·5) years]. The pattern of results for alcohol poisoning and self-reported alcohol consumption was similar in UK Biobank. In IPD-Work and UK Biobank, differences in disease-free years between self-reported moderate drinkers and heavy drinkers were 1·5 years or less. Individuals with alcohol poisonings or heavy self-reported overall consumption combined with a binge drinking habit have a marked 3- to 6-year loss in healthy longevity. Differences in disease-free life between categories of self-reported weekly alcohol consumption were smaller. Medical Research Council, National Institute on Aging, NordForsk, Academy of Finland, Finnish Work Environment Fund.

Sections du résumé

Background UNASSIGNED
Heavy alcohol consumption increases the risk of several chronic diseases. In this multicohort study, we estimated the number of life-years without major chronic diseases according to different characteristics of alcohol use.
Methods UNASSIGNED
In primary analysis, we pooled individual-level data from up to 129,942 adults across 12 cohort studies with baseline data collection on alcohol consumption, drinking patterns, and history between 1986 and 2005 (the IPD-Work Consortium). Self-reported alcohol consumption was categorised according to UK guidelines - non-drinking (never or former drinkers); moderate consumption (1-14 units); heavy consumption (>14 units per week). We further subdivided moderate and heavy drinkers by binge drinking pattern (alcohol-induced loss of consciousness). In addition, we assessed problem drinking using linked data on hospitalisations due to alcohol abuse or poisoning. Follow-up for chronic diseases for all participants included incident type 2 diabetes, coronary heart disease, stroke, cancer, and respiratory disease (asthma and chronic obstructive pulmonary disease) as ascertained via linkage to national morbidity and mortality registries, repeated medical examinations, and/or self-report. We estimated years lived without any of these diseases between 40 and 75 years of age according to sex and characteristics of alcohol use. We repeated the main analyses using data from 427,621 participants in the UK Biobank cohort study.
Findings UNASSIGNED
During 1·73 million person-years at risk, 22,676 participants in IPD-Work cohorts developed at least one chronic condition. From age 40 to 75 years, never-drinkers [men: 29·3 (95%CI 27·9-30·8) years, women 29·8 (29·2-30·4) years)] and moderate drinkers with no binge drinking habit [men 28·7 (28·4-29·0) years, women 29·6 (29·4-29·7) years] had the longest disease-free life span. A much shorter disease-free life span was apparent in participants who experienced alcohol poisoning [men 23·4 (20·9-26·0) years, women 24·0 (21·4-26·5) years] and those with self-reported heavy overall consumption and binge drinking [men: 26·0 (25·3-26·8), women 27·5 (26·4-28·5) years]. The pattern of results for alcohol poisoning and self-reported alcohol consumption was similar in UK Biobank. In IPD-Work and UK Biobank, differences in disease-free years between self-reported moderate drinkers and heavy drinkers were 1·5 years or less.
Interpretation UNASSIGNED
Individuals with alcohol poisonings or heavy self-reported overall consumption combined with a binge drinking habit have a marked 3- to 6-year loss in healthy longevity. Differences in disease-free life between categories of self-reported weekly alcohol consumption were smaller.
Funding UNASSIGNED
Medical Research Council, National Institute on Aging, NordForsk, Academy of Finland, Finnish Work Environment Fund.

Identifiants

pubmed: 35664051
doi: 10.1016/j.lanepe.2022.100417
pii: S2666-7762(22)00111-9
pmc: PMC9160494
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100417

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG034454
Pays : United States
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R56 AG052519
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG056477
Pays : United States

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

No disclosures were reported.

Références

J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):74-84
pubmed: 8568140
BMJ. 2014 Jul 10;349:g4164
pubmed: 25011450
Addiction. 2017 Jun;112(6):968-1001
pubmed: 28220587
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Lancet Public Health. 2018 Nov;3(11):e545-e554
pubmed: 30409406
Respir Med. 2012 Feb;106(2):184-8
pubmed: 22129491
Eur J Epidemiol. 2017 Apr;32(4):317-326
pubmed: 28409278
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
BMJ. 2011 Feb 22;342:d671
pubmed: 21343207
Lancet Public Health. 2020 Mar;5(3):e140-e149
pubmed: 32007134
Lancet Public Health. 2020 Jun;5(6):e324-e332
pubmed: 32504585
Int J Obes (Lond). 2017 May;41(5):769-775
pubmed: 28138135
Lancet. 2019 May 4;393(10183):1831-1842
pubmed: 30955975
Lancet Public Health. 2018 Oct;3(10):e490-e497
pubmed: 30177479
BMC Public Health. 2017 Jul 21;18(1):43
pubmed: 28732487
Int J Cardiol. 2014 Jul 1;174(3):669-77
pubmed: 24820756
Lancet. 2007 Jun 16;369(9578):2001-2009
pubmed: 17574092
PLoS One. 2016 Feb 05;11(2):e0148765
pubmed: 26849558
J Epidemiol Community Health. 2004 Apr;58(4):321-6
pubmed: 15026447
Circulation. 2009 Jul 21;120(3):237-44
pubmed: 19597054
Alcohol Alcohol. 2020 Aug 14;55(5):554-563
pubmed: 32491170
Eur J Epidemiol. 2016 May;31(5):455-68
pubmed: 26781655
Stat Med. 2002 Aug 15;21(15):2175-97
pubmed: 12210632
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959
pubmed: 24239921
PLoS Med. 2019 Feb 4;16(2):e1002741
pubmed: 30716101
Ann Intern Med. 2004 Feb 3;140(3):211-9
pubmed: 14757619
BMJ. 2020 Jan 8;368:l6669
pubmed: 31915124
Alcohol Res. 2016;38(1):83-94
pubmed: 27159815
Int J Epidemiol. 2016 Aug;45(4):1260-1270
pubmed: 27488415
JAMA Netw Open. 2020 Sep 1;3(9):e2016084
pubmed: 32902651
Lancet. 2012 Oct 27;380(9852):1491-7
pubmed: 22981903
JAMA Intern Med. 2020 May 1;180(5):760-768
pubmed: 32250383
Cancer. 2011 Feb 15;117(4):714-22
pubmed: 20882563
Popul Res Policy Rev. 2013 Jun;32(3):325-352
pubmed: 25045194

Auteurs

Solja T Nyberg (ST)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.
Faculty of Social Sciences, University of Tampere, Tampere, Finland.
Finnish Institute of Occupational Health, Helsinki, Finland.

G David Batty (GD)

Department of Epidemiology and Public Health, University College London, London, UK.

Jaana Pentti (J)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.
Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland.
Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.

Ida E H Madsen (IEH)

National Research Centre for the Working Environment, Copenhagen, Denmark.

Lars Alfredsson (L)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Centre for Occupational and Environmental Medicine, Stockholm County Council, Sweden.

Jakob B Bjorner (JB)

National Research Centre for the Working Environment, Copenhagen, Denmark.

Marianne Borritz (M)

Bispebjerg University Hospital, Copenhagen, Denmark.

Hermann Burr (H)

Federal Institute for Occupational Safety and Health (BAuA), Berlin, Germany.

Jenni Ervasti (J)

Finnish Institute of Occupational Health, Helsinki, Finland.

Marcel Goldberg (M)

Paris Descartes University, Paris, France.
Inserm UMS 011, Population-Based Epidemiological Cohorts Unit, Villejuif, France.

Markus Jokela (M)

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Anders Knutsson (A)

Department of Health Sciences, Mid Sweden University, Sundsvall, Sweden.

Aki Koskinen (A)

Finnish Institute of Occupational Health, Helsinki, Finland.

Tea Lallukka (T)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.

Joni V Lindbohm (JV)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.

Martin L Nielsen (ML)

AS3 Companies, Viby J, Denmark.

Tuula Oksanen (T)

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

Jan H Pejtersen (JH)

VIVE-The Danish Center for Social Science Research, Copenhagen, Denmark.

Olli Pietiläinen (O)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.

Ossi Rahkonen (O)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.

Reiner Rugulies (R)

National Research Centre for the Working Environment, Copenhagen, Denmark.
Department of Public Health and Department of Psychology, University of Copenhagen, Copenhagen, Denmark.

Martin J Shipley (MJ)

Department of Epidemiology and Public Health, University College London, London, UK.

Pyry N Sipilä (PN)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.

Jeppe K Sørensen (JK)

National Research Centre for the Working Environment, Copenhagen, Denmark.

Sari Stenholm (S)

Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland.
Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.

Sakari Suominen (S)

Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland.
School of Health Science, University of Skövde, Skövde, Sweden.

Ari Väänänen (A)

Finnish Institute of Occupational Health, Helsinki, Finland.

Jussi Vahtera (J)

Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland.
Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.

Marianna Virtanen (M)

School of Educational Sciences and Psychology, University of Eastern Finland, Joensuu, Finland.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Hugo Westerlund (H)

Stress Research Institute, Stockholm University, Stockholm, Sweden.

Marie Zins (M)

Paris Descartes University, Paris, France.
Inserm UMS 011, Population-Based Epidemiological Cohorts Unit, Villejuif, France.

Archana Singh-Manoux (A)

Department of Epidemiology and Public Health, University College London, London, UK.
Inserm U1153, Epidemiology of Ageing and Neurodegenerative Diseases, Université de Paris, France.

Mika Kivimäki (M)

Clinicum, Department of Public Health, Faculty of Medicine, University of Helsinki, Tukholmankatu 8B, FI-00014 Helsingin yliopisto, Helsinki, Finland.
Department of Epidemiology and Public Health, University College London, London, UK.

Classifications MeSH